Do Hormones Trigger RLS in Women? Evidence Review

✔ Reviewed and updated by Dennis VT, MSc — Editor-in-Chief · Global Health Beacon Editorial Team · February 19, 2026

Your legs won’t stop moving at night, sleep feels impossible, and you’re exhausted – if you’re experiencing restless legs syndrome symptoms, you’re not alone, and hormones might be the hidden culprit behind your struggle.

Understanding restless legs syndrome (RLS)

Restless Legs Syndrome is a neurological condition that creates an almost irresistible urge to move your legs, typically accompanied by uncomfortable sensations like tingling, burning, or crawling feelings. Imagine sitting down to relax after a long day, only to feel an overwhelming need to shift, stretch, or walk around within minutes. This isn’t restlessness in the typical sense; it’s a genuine neurological drive. The condition typically intensifies during periods of inactivity, particularly in the evening and night hours, which explains why so many women report severe sleep disruption. RLS affects roughly 5-10% of the population, with women experiencing it more frequently than men, especially as they age. The sensations can range from mildly annoying to genuinely debilitating, sometimes forcing people out of bed multiple times per night. Understanding RLS as a neurological disorder, rather than a psychological issue or simple anxiety, is crucial for proper recognition and management.

Hormonal influence on RLS

Research increasingly points to a meaningful connection between hormonal fluctuations and RLS symptom severity in women. Hormones like estrogen and progesterone don’t simply regulate reproduction; they influence neurotransmitter systems throughout the brain and body, including dopamine pathways directly linked to RLS. When hormone levels shift, they can alter how your brain produces and uses dopamine, a chemical messenger critical for movement control. Additionally, hormones affect iron metabolism and absorption, and iron deficiency is a well-established risk factor for RLS. Many women notice their symptoms worsen during specific phases of their menstrual cycle, intensify during perimenopause, or change dramatically after menopause. Some women report that their RLS symptoms appeared or worsened during pregnancy, when hormonal changes are most dramatic. This hormonal connection explains why RLS patterns in women often differ significantly from those in men, and why a woman’s symptom severity may fluctuate unpredictably over months or years.

The connection between hormones and RLS

Estrogen plays a complex role in RLS severity. Research has documented that women often experience worsening symptoms during the luteal phase of their menstrual cycle, when estrogen levels drop. Similarly, the dramatic estrogen decline during menopause frequently triggers or intensifies RLS symptoms in previously unaffected women, or significantly worsens existing symptoms. Some studies suggest that estrogen supports dopamine receptor function, meaning lower estrogen may compromise the brain’s ability to regulate movement effectively. Progesterone interacts with dopamine systems in ways that researchers are still working to fully understand, but evidence suggests that progesterone fluctuations can influence symptom intensity. The menstrual cycle creates a monthly rhythm of hormonal peaks and valleys, and many women report a predictable pattern where RLS symptoms spike during specific cycle phases. Tracking these patterns can help you and your healthcare provider identify whether hormones are a significant factor in your particular experience. Some women find their symptoms nearly disappear during the follicular phase when estrogen is rising, then return forcefully during the luteal phase. This cyclical pattern is a strong indicator that hormones are playing a meaningful role in your RLS.

1. Track your RLS symptoms daily for at least two menstrual cycles, noting severity, time of day, and which cycle phase you are in to identify patterns.
2. Keep a detailed log of hormone-related changes like mood shifts, sleep quality, and physical sensations to correlate with symptom fluctuations.
3. Discuss your symptom patterns with a healthcare provider who can assess whether hormone-related factors warrant further investigation or intervention.
4. Consider whether your symptoms align with known hormonal transition periods like menstruation, ovulation, perimenopause, or pregnancy.
5. If patterns emerge, explore whether hormone-related treatment options might be appropriate for your specific situation and health profile.

Genetic predisposition and RLS

While hormones significantly influence RLS expression, genetics form the underlying foundation of susceptibility. If your mother, grandmother, or sister experienced RLS, your own risk is substantially elevated. Research indicates that approximately 50-60% of people with RLS have a family history of the condition, suggesting strong genetic inheritance patterns. Genetics determine how your brain produces and processes dopamine, how efficiently your body absorbs and uses iron, and how sensitive your nervous system is to hormonal fluctuations. Think of genetics as setting your baseline vulnerability, while hormones act as the trigger that activates or intensifies symptoms. A woman might inherit the genetic predisposition for RLS but not develop noticeable symptoms until hormonal changes during perimenopause push her over the threshold. Conversely, another woman with the same genetic background might experience symptoms starting in her twenties if other factors like iron deficiency or stress align. Understanding that RLS has a genetic component can be reassuring because it removes blame or shame; this isn’t something you caused through lifestyle choices, though lifestyle factors can certainly influence symptom severity.

Treatment strategies for hormone-related RLS

Managing RLS when hormones are a contributing factor requires a personalized approach because what works for one woman may not work for another. Some women find relief through iron supplementation, particularly if testing reveals low iron stores, since iron supports dopamine function. Others explore hormone replacement therapy during menopause, though the relationship between HRT and RLS is complex; some women improve while others see no change or worsening. Lifestyle modifications like regular exercise, particularly leg-focused activities like walking or cycling, can reduce symptom severity for many women. Avoiding caffeine, alcohol, and certain medications that can worsen RLS is important for symptom management. Some women benefit from evening stretching routines, warm baths, or massage to reduce the uncomfortable sensations. Sleep hygiene improvements, including consistent bedtimes and cool, dark sleeping environments, help because RLS symptoms intensify with fatigue. Compression stockings or leg wraps provide relief for some women by creating gentle pressure that counteracts the uncomfortable sensations. Working with a healthcare provider to identify which combination of approaches works best for your unique hormonal and genetic profile is essential for effective long-term management.

Future research directions

Scientists are actively investigating the precise mechanisms through which hormonal fluctuations trigger or worsen RLS symptoms in women, with several promising research directions emerging. Advanced neuroimaging studies are revealing how estrogen and progesterone affect dopamine receptor density and function in brain regions controlling movement. Researchers are examining whether certain women might benefit from targeted hormone therapies specifically designed to stabilize symptoms rather than traditional hormone replacement therapy. Genetic studies are identifying specific genes that may increase RLS susceptibility and interact with hormonal factors, potentially leading to personalized risk assessments. Clinical trials are testing whether iron supplementation combined with hormone management produces better outcomes than either approach alone. Scientists are also exploring whether understanding the hormone-RLS connection might reveal new treatment targets for women who don’t respond to current medications. As this research evolves, women with RLS may eventually have access to more precise, individualized treatment plans based on their unique genetic and hormonal profiles rather than one-size-fits-all approaches.

The relationship between hormones and restless legs syndrome in women is multifaceted and deeply interconnected. Hormonal fluctuations throughout the menstrual cycle, during pregnancy, and across menopause can significantly influence RLS symptom severity through effects on dopamine production, iron metabolism, and neurotransmitter regulation. Genetic predisposition provides the foundation for RLS susceptibility, while hormonal changes act as triggers or amplifiers of symptoms. Understanding this complex interplay between genetics, hormones, and neurological function empowers women to recognize patterns in their own experiences and work with healthcare providers to develop truly personalized treatment approaches. The evidence clearly demonstrates that effective RLS management for women must account for hormonal factors alongside other contributing elements.

Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice. Always consult a healthcare professional for personal guidance.

This article has been prepared and reviewed by the GlobalHealthBeacon editorial team and is based on current medical research and published scientific literature available in 2026. It provides structured, evidence-based information to support informed health decisions.

← Back to the Main page on: restless legs syndrome symptoms